Revenue
2022
2023
2024
2025
Baird Medical Investment Holdings Ltd (BDMD)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $22.5M | $37.0M | $31.5M | $35.1M |
| Gross profit | $18.9M | $32.7M | $27.2M | $28.0M |
| Research & development | $20.1M | $6.2M | $4.3M | $3.9M |
| Operating expenses | $44.5M | $17.3M | $15.4M | $14.4M |
| Operating income | −$25.6M | $15.3M | $11.9M | $13.6M |
| EBITDAderived | −$24.5M | $16.5M | $12.9M | $14.5M |
| Net income | −$27.3M | $12.5M | $10.5M | $12.8M |
| Basic EPSper diluted share | -$0.98 | $0.57 | $0.51 | $0.49 |
| Diluted EPSper diluted share | -$0.98 | $0.57 | $0.51 | $0.49 |